Immunicon Corp - Withdrawal of Registration Statement (RW)
March 19 2008 - 3:17PM
Edgar (US Regulatory)
IMMUNICON CORPORATION
3401 MASONS MILL ROAD, SUITE 100
HUNTINGDON VALLEY, PENNSYLVANIA 19006
(215) 830-0777
March 19, 2008
VIA EDGAR
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
|
|
|
Re:
|
|
Immunicon Corporation
|
|
|
Registration Statement on Form S-3 (
File No. 333-145634
)
|
|
|
Application for Withdrawal
|
Ladies and Gentlemen:
Pursuant to Rule 477 of Regulation C promulgated under the Securities Act of 1933, as amended (the Securities Act), Immunicon Corporation, a Delaware corporation (the Company), hereby respectfully requests the
withdrawal of its Registration Statement on Form S-3 (File No. 333-145634) and all amendments and all exhibits thereto (the Registration Statement), and that an order of the Securities and Exchange Commission granting such
withdrawal be issued for the Companys file relating to the Registration Statement on the date hereof or at the earliest practical date thereafter.
The Company requests this withdrawal because it has elected not to pursue the registration of the securities included in the Registration Statement at this time. Through the date hereof, the Registration Statement has not been declared
effective and no securities have been sold in connection with the Registration Statement.
Please provide the Company with a copy of the order granting
withdrawal of the Registration Statement as soon as it is available to my attention at 3401 Masons Mill Road, Suite 100, Huntingdon Valley, Pennsylvania 19006.
If you have any questions regarding this application, please contact me at (215) 830-0777.
Sincerely,
|
|
|
IMMUNICON CORPORATION
|
|
|
By:
|
|
/s/ Byron D. Hewett
|
Name:
|
|
Byron D. Hewett
|
Title:
|
|
President and Chief Executive Officer
|
Immunicon (NASDAQ:IMMC)
Historical Stock Chart
From May 2024 to Jun 2024
Immunicon (NASDAQ:IMMC)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Immunicon (MM) (NASDAQ): 0 recent articles
More Immunicon Corp News Articles